Is Robotic Superior to Laparoscopic Approach for Radical Nephroureterectomy with Bladder Cuff Excision in Treating Upper Urinary Tract Urothelial Carcinoma?

Journal: Journal of endourology
PMID:

Abstract

Laparoscopic nephroureterectomy (LNU) has become popular in treating upper urinary tract urothelial carcinoma (UTUC) and an emerging trend was observed in robotic approaches. Therefore, we compared robot-assisted radical nephroureterectomy (RANU) and LNU for the treatment of UTUC. This observational and retrospective case-series study included UTUC patients who underwent LNU or RANU. A pure laparoscopic approach was adopted in the LNU treatment group, and bladder cuff excision (BCE) was performed mostly with the open approach. Either the da Vinci Si or Xi surgical system was used for RANU. Extravesical BCE was performed, and bladder defects were closed intracorporeally. Perioperative and oncologic outcomes were compared between the LNU and RANU groups. A total of 231 patients who underwent RANU ( = 87) or LNU ( = 144) were included. No significant differences were noted between the groups in terms of demographics, tumor characteristics, operative time, catheter time, or complications. Compared with LNU, RANU had a lower intraoperative blood loss (30 vs. 150 mL,  < 0.001) and shorter postoperative hospital stay (8 vs. 9 days,  = 0.009). The 5-year overall survival, cancer-specific survival, and bladder recurrence-free survival were comparable between the groups. Compared with LNU, RANU had similar perioperative and oncologic outcomes but was superior in terms of intraoperative blood loss and postoperative length of hospital stay. However, considering the potential biases owing to the heterogeneity of our cases, the interpretation of the results must be very cautious.

Authors

  • Yu-Pin Huang
    Department of Urology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Eric Yi-Hsiu Huang
    Department of Urology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Hsiao-Jen Chung
    Shu-Tien Urological Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
  • Meng-Che Tai
    Department of Urology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Tzu-Hao Huang
    Department of Urology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Tzu-Chun Wei
    Department of Urology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Yu-Hua Fan
    Department of Urology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Chih-Chieh Lin
    Department of Urology, Taipei Veterans General Hospital, Institute of Clinical Medicine, 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan; Department of Urology, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Tzu-Ping Lin
    School of Medicine, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.
  • Junne-Yih Kuo
    Department of Urology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Shing-Hwa Lu
    Department of Urology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Yen-Hwa Chang
    Department of Urology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Alex Tong-Lung Lin
    Department of Urology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • William Ji-Sien Huang
    Department of Urology, Taipei Veterans General Hospital, Taipei, Taiwan.